The German nationwide and anonymous advertising format of Deutsche Post is called POSTAKTUELL and is published regularly in large print runs. The stack of advertising is wrapped in a foil and the practical added value for the recipient is the TV guide. The front of POSTAKTUELL is particularly eye-catching and anyone who advertises there will reach a lot of people. In the meantime, advertising for products and applications with active ingredients from the cannabis plant is already being done there. CBD reaches the general public and despite the Corona Pandemic, the industry's stocks are running in turnaround mode and have left the lows.
Natural ingredients with value
The active ingredients of the cannabis plant have a long history. For about ten years they have been experiencing a renaissance and the possibilities of herbal therapy are becoming increasingly important. Manufacturers of products are expanding their spectrum of
use possibilities for health and well-being according to the desires and needs of their target groups. In addition to medical preparations, more and more cosmetic and modern lifestyle products with the CBD label are available. The trend in modern society is moving towards natural ingredients and this has been made possible by the legalisation of the cannabis plant.
New market with competitive pressure
Put simply, the origin of the recent cannabis movement started in Canada about ten years ago. This is also where the largest companies in the industry were established. With valuations beyond the billion-dollar mark, investors and entrepreneurs around the globe were attracted. Since then, many people have been trying their luck in the industry to get
a slice of the pie in the growth market. After the never-ending hype of the cannabis industry, more than a year ago market participants and investors went into a kind of hangover mood. Too many companies need too much money to build up and profitability was not forthcoming.
Recovery phase makes stocks rise
After a cooling-down phase of the market and enormous price losses of the shares of the public companies, the countermovement now seems to be starting. A consolidation phase often has a healing effect and it can usually be worthwhile to
spread the capital to be invested in order to be diversified in the industry. At a level of 4.70 CAD, the market value of
Aphria (TSX: APHA) is around CAD 1.25 billion.
Aurora Cannabis (TSX: ACB) has a market value of around CAD 1.56 billion at a share price of CAD 15.35.
Canopy Growth (TSX: WEED) is valued as a heavyweight at over CAD 7.83 billion with a stock price of CAD 22.33
Young company with potential
A young supplier with pure ingredients is
EXMceuticals (CSE: EXM) and is focused on the
health care industry. With a share price of CAD 0.475, the company has a market value of CAD 17.36 million. EXMceuticals is based in Lisbon, Portugal, with its operational team and plans sales in the EU from there. The German company Symrise has set an example of success in the ingredients sector. At EUR 94.48, the company is now valued at over EUR 12.81 billion on the stock exchange.
CONFLICT OF INTEREST & RISK NOTE
We would like to point out that Apaton Finance GmbH, the owner of news.financial, as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our ´
Conflict of Interest & Risk Disclosure´.